ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
16.99024
-0.30%
Brent Oil
81.295
0.00%
Bitcoin
67,587.50
0.16%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Enochian Biosciences Inc (ENOB)

  7. Enochian Biosciences Inc (ENOB) Noticias

ENOB

Enochian Biosciences (ENOB)

Enochian Biosciences Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ENOB
FechaHoraFuenteTítuloSímboloCompañía
30/04/202415:49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENOBEnochian Biosciences Inc
24/04/202416:23Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ENOBEnochian Biosciences Inc
08/04/202416:44Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ENOBEnochian Biosciences Inc
19/03/202410:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENOBEnochian Biosciences Inc
13/03/202414:45Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ENOBEnochian Biosciences Inc
16/02/202408:38Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:ENOBEnochian Biosciences Inc
14/02/202416:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ENOBEnochian Biosciences Inc
16/01/202416:25Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ENOBEnochian Biosciences Inc
03/01/202407:00Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:ENOBEnochian Biosciences Inc
22/12/202316:25Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNASDAQ:ENOBEnochian Biosciences Inc
30/10/202308:15Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:ENOBEnochian Biosciences Inc
20/10/202320:47Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ENOBEnochian Biosciences Inc
28/06/202306:45Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ENOBEnochian Biosciences Inc
23/06/202316:00GlobeNewswire Inc.Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder MeetingNASDAQ:ENOBEnochian Biosciences Inc
08/06/202307:45GlobeNewswire Inc.Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA ReviewNASDAQ:ENOBEnochian Biosciences Inc
19/05/202316:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ENOBEnochian Biosciences Inc
19/05/202316:01Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ENOBEnochian Biosciences Inc
16/05/202315:35Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ENOBEnochian Biosciences Inc
12/05/202316:27Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ENOBEnochian Biosciences Inc
04/04/202315:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ENOBEnochian Biosciences Inc
03/04/202308:00GlobeNewswire Inc.Enochian BioSciences’ CEO Letter to ShareholdersNASDAQ:ENOBEnochian Biosciences Inc
29/03/202308:00GlobeNewswire Inc.Enochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading ResearcherNASDAQ:ENOBEnochian Biosciences Inc
13/03/202307:30GlobeNewswire Inc.Enochian BioSciences Achieves Full Compliance with NASDAQ Filing RequirementsNASDAQ:ENOBEnochian Biosciences Inc
23/02/202315:04GlobeNewswire Inc.Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended December 31, 2022NASDAQ:ENOBEnochian Biosciences Inc
30/11/202216:20GlobeNewswire Inc.Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended September 30, 2022NASDAQ:ENOBEnochian Biosciences Inc
15/11/202216:24Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:ENOBEnochian Biosciences Inc
24/10/202207:00GlobeNewswire Inc.Enochian BioSciences Forges Ahead With Focused Approach, Promising FutureNASDAQ:ENOBEnochian Biosciences Inc
21/10/202216:00TipRanksEnochian Biosciences receives Nasdaq notice regarding delayed filingNASDAQ:ENOBEnochian Biosciences Inc
21/10/202216:00GlobeNewswire Inc.Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Annual Report on Form 10-KNASDAQ:ENOBEnochian Biosciences Inc
17/10/202207:30GlobeNewswire Inc.Enochian BioSciences Awarded U.S. Patent For Its Promising Oncology PlatformNASDAQ:ENOBEnochian Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:ENOB

Su Consulta Reciente

NASDAQ
TRML
Tourmaline Bio
LSE
IE1H
USOTC
TNSTF
Jade Power (CE)
NYSE
RGA.A
USOTC
DUFRY
Avolta (PK)
NYSE
BDG.A
Bandag A
TSX
5534
Angel
USOTC
QQREF
Quebec Rare Earth Elements (PK)
COIN
PLANETTUST
PLANET
COIN
BONEUST
BONE SHIBASWAP
USOTC
GCEA
Griffin Realty (CE)
COIN
ZKUST
Poriot
EU
2935S
2935S
NYSE
NATL
National Interstate
USOTC
YKLTF
Yakult Honsha (PK)
COIN
PRNTETH
PrimeNumbers
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados